Literature DB >> 12042766

Adenovirus-5 E1A: paradox and paradigm.

Steven M Frisch1, Joe S Mymryk.   

Abstract

The adenovirus early region 1A (E1A) proteins were described originally as immortalizing oncoproteins that altered transcription in rodent cells. Surprisingly, the 243-amino-acid form of adenovirus-5 E1A was found subsequently to reverse-transform many human tumour cells. Tumour suppression apparently results from the ability of E1A to re-programme transcription in tumour cells, and the molecular basis of this intriguing effect is now beginning to emerge. These discoveries have provided a tool with which to study the regulation of fundamental cellular processes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12042766     DOI: 10.1038/nrm827

Source DB:  PubMed          Journal:  Nat Rev Mol Cell Biol        ISSN: 1471-0072            Impact factor:   94.444


  121 in total

Review 1.  Human pathogens and the host cell SUMOylation system.

Authors:  Peter Wimmer; Sabrina Schreiner; Thomas Dobner
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

2.  Adenovirus protein VII condenses DNA, represses transcription, and associates with transcriptional activator E1A.

Authors:  Jeffrey S Johnson; Yvonne N Osheim; Yuming Xue; Margaux R Emanuel; Peter W Lewis; Alex Bankovich; Ann L Beyer; Daniel A Engel
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

3.  E1B-55-kilodalton protein is not required to block p53-induced transcription during adenovirus infection.

Authors:  Urs Hobom; Matthias Dobbelstein
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

4.  E1A and E1B proteins inhibit inflammation induced by adenovirus.

Authors:  Jerome Schaack; Michael L Bennett; Jeff D Colbert; Andres Vazquez Torres; Gerald H Clayton; David Ornelles; John Moorhead
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-19       Impact factor: 11.205

5.  CRM1-dependent transport supports cytoplasmic accumulation of adenoviral early transcripts.

Authors:  Melanie Schmid; Ramon A Gonzalez; Thomas Dobner
Journal:  J Virol       Date:  2011-12-14       Impact factor: 5.103

6.  Cellular GCN5 is a novel regulator of human adenovirus E1A-conserved region 3 transactivation.

Authors:  Jailal N G Ablack; Michael Cohen; Gobi Thillainadesan; Gregory J Fonseca; Peter Pelka; Joe Torchia; Joe S Mymryk
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

7.  Downregulation of microRNA miR-520h by E1A contributes to anticancer activity.

Authors:  Jen-Liang Su; Poshen B Chen; Ya-Huey Chen; Shang-Chih Chen; Yi-Wen Chang; Yi-Hua Jan; Xiaoyun Cheng; Michael Hsiao; Mien-Chie Hung
Journal:  Cancer Res       Date:  2010-05-25       Impact factor: 12.701

8.  The Dual Nature of Nek9 in Adenovirus Replication.

Authors:  Richard Jung; Sandi Radko; Peter Pelka
Journal:  J Virol       Date:  2015-12-16       Impact factor: 5.103

9.  Transactivation of E2F-regulated genes by polyomavirus large T antigen: evidence for a two-step mechanism.

Authors:  Maria Nemethova; Michael Smutny; Erhard Wintersberger
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

10.  Mapping the interactions of adenoviral E1A proteins with the p160 nuclear receptor coactivator binding domain of CBP.

Authors:  Peter Haberz; Munehito Arai; Maria A Martinez-Yamout; H Jane Dyson; Peter E Wright
Journal:  Protein Sci       Date:  2016-10-15       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.